121 related articles for article (PubMed ID: 31211077)
41. Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study.
El-Dakhakhny AS; Gharib T; Issam A; El-Karamany TM
Arab J Urol; 2019; 17(4):270-278. PubMed ID: 31723444
[No Abstract] [Full Text] [Related]
42. Transurethral resection of the prostate achieves favorable outcomes in stroke patients with symptomatic benign prostate hyperplasia.
Hou CP; Lin YH; Chen TH; Chang PL; Juang HH; Chen CL; Yang PS; Tsui KH
Aging Male; 2018 Mar; 21(1):9-16. PubMed ID: 28763255
[TBL] [Abstract][Full Text] [Related]
43. Two-year results of transurethral resection of the prostate versus four 'less invasive' treatment options.
Schatzl G; Madersbacher S; Djavan B; Lang T; Marberger M
Eur Urol; 2000 Jun; 37(6):695-701. PubMed ID: 10828670
[TBL] [Abstract][Full Text] [Related]
44. Prostate Artery Embolization for Lower Urinary Tract Symptoms in Men Unfit for Surgery.
Malling B; Lönn L; Jensen RJ; Lindh M; Frevert S; Brasso K; Røder MA
Diagnostics (Basel); 2019 Apr; 9(2):. PubMed ID: 31027211
[TBL] [Abstract][Full Text] [Related]
45. [Transurethral resection of the prostate in the treatment of benign prostatic hyperplasia].
Bardos A; Hornak M; Novotny V
Bratisl Lek Listy; 2001; 102(2):79-83. PubMed ID: 11396128
[TBL] [Abstract][Full Text] [Related]
46. GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation.
Pereira-Correia JA; de Moraes Sousa KD; Santos JB; de Morais Perpétuo D; Lopes-da-Silva LF; Krambeck RL; Muller VJ; Vaz FP
BJU Int; 2012 Oct; 110(8):1184-9. PubMed ID: 22257240
[TBL] [Abstract][Full Text] [Related]
47. Recurrent Dystrophic Calcification of the Prostatic Resection Cavity After Transurethral Resection of the Prostate: Clinical Presentation and Endoscopic Management.
Zumstein V; Betschart P; Müllhaupt G; Jochum W; Schmid HP; Abt D
J Endourol Case Rep; 2017; 3(1):81-83. PubMed ID: 28736747
[No Abstract] [Full Text] [Related]
48. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
Cornu JN; Ahyai S; Bachmann A; de la Rosette J; Gilling P; Gratzke C; McVary K; Novara G; Woo H; Madersbacher S
Eur Urol; 2015 Jun; 67(6):1066-1096. PubMed ID: 24972732
[TBL] [Abstract][Full Text] [Related]
49. Technique considerations and complication management in transurethral resection of the prostate and photoselective vaporization of the prostate.
Welliver C; Helo S; McVary KT
Transl Androl Urol; 2017 Aug; 6(4):695-703. PubMed ID: 28904902
[TBL] [Abstract][Full Text] [Related]
50. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract][Full Text] [Related]
51. Randomized study of transurethral resection of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia.
Küpeli S; Yilmaz E; Soygür T; Budak M
J Endourol; 2001 Apr; 15(3):317-21. PubMed ID: 11339401
[TBL] [Abstract][Full Text] [Related]
52. Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia.
Fowler C; McAllister W; Plail R; Karim O; Yang Q
Health Technol Assess; 2005 Feb; 9(4):iii-iv, 1-30. PubMed ID: 15698525
[TBL] [Abstract][Full Text] [Related]
53. Photoselective vaporization of the prostate with GreenLight 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis of randomized controlled trials.
Zang YC; Deng XX; Yang DR; Xue BX; Xu LJ; Liu XL; Zhou YB; Shan YX
Lasers Med Sci; 2016 Feb; 31(2):235-40. PubMed ID: 26712715
[TBL] [Abstract][Full Text] [Related]
54. Granulomatous and xanthogranulomatous prostatitis: A case report.
A AN; Karzoun MZ; Abdelfattah O; Ibrahim T
Urol Case Rep; 2022 Jan; 40():101887. PubMed ID: 34712584
[TBL] [Abstract][Full Text] [Related]
55. Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy.
Pham H; Sharma P
Can J Urol; 2018 Apr; 25(2):9228-9237. PubMed ID: 29679999
[TBL] [Abstract][Full Text] [Related]
56. Comparative randomized study on the efficaciousness of endoscopic bipolar prostate resection versus monopolar resection technique. 3 year follow-up.
Giulianelli R; Albanesi L; Attisani F; Gentile BC; Vincenti G; Pisanti F; Shestani T; Mavilla L; Granata D; Schettini M
Arch Ital Urol Androl; 2013 Jun; 85(2):86-91. PubMed ID: 23820656
[TBL] [Abstract][Full Text] [Related]
57. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
[TBL] [Abstract][Full Text] [Related]
58. Outcome of transurethral resection of prostate in clinical benign prostatic hyperplasia.
Bozdar HR; Memon SR; Paryani JP
J Ayub Med Coll Abbottabad; 2010; 22(4):194-6. PubMed ID: 22455296
[TBL] [Abstract][Full Text] [Related]
59. Benign prostatic hyperplasia: mode of presentation and postoperative outcome.
Khan M; Khan AL; Khan S; Nawaz H
J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691
[TBL] [Abstract][Full Text] [Related]
60. Transurethral resection of the prostate in kidney transplant recipients: urological and renal functional outcomes at long-term follow-up.
Volpe A; Billia M; Quaglia M; Vidali M; Marchioro G; Ceratti G; Sogni F; De Lorenzis E; De Angelis P; Airoldi A; Stratta P; Terrone C
BJU Int; 2013 Aug; 112(3):386-93. PubMed ID: 23496755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
